UTHR - United Therapeutics motion for restraining order over Liquidia's Yutrepia denied
2024-03-31 08:00:00 ET
More on Liquidia
- Liquidia Corporation (LQDA) Q4 2023 Earnings Call Transcript
- Liquidia Corporation: A Complicated Tale
- Liquidia Continues To Expand Their Growth Vs. MannKind's Growth In Share Prices
- Liquidia gains after court win in patent dispute with United Therapeutics
- Liquidia says FDA review for new Yutrepia indication extended